跳至主要内容
临床试验/JPRN-jRCT2031200413
JPRN-jRCT2031200413已完成1 期

A phase 1, randomized, 2-way cross over study to assess the effect of cyclosporine on the pharmacokinetics of S-600918, a 1-sequence crossover study to assess the effect of S-600918 on the pharmacokinetics of midazolam, and a randomized, 2-way cross over study to assess the food-effect of S-600918, in healthy adult participants

agata Tsutae0 个研究点目标入组 42 人开始时间: 2021年3月11日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 55age old(—)
性别
Male

入选标准

  • Apparently healthy as determined by the investigator or subinvestigator based on medical assessment.
  • -Weight within the range 50 kg (inclusive) to 85 kg (exclusive), and body mass index (BMI) within the range 18.5 kg/m2 (inclusive) to 25.0 kg/m2 (inclusive).
  • -Capable of giving the signed ICF as described in this protocol which includes compliance with the requirements and deadlines listed in the ICF and in this protocol.

排除标准

  • -History or presence of significantly disorders that, in the opinion of the investigator or subinvestigator, would constitute a safety concern or donfound data interaption.
  • -Exposure to more than 4 study drugs within 12 months prior to the first dose of study intervention.
  • -Previous administration of S-600918.
  • -Ineligibility for the study as considered by the investigator or subinvestigator.

研究者

发起方
agata Tsutae

相似试验